Product Information
MUPIROCIN 2% OINTMENT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1456 per GM under NDC 68462018022. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 8, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462018022
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
MUPIROCINApproval Type
Generic (ANDA)
FDA Application
ANDA090480FDA Approved
6/8/2011
TE Code
AB
On Market Since
6/8/2011
Pharmacological Classes
Price Statistics
The NADAC for MUPIROCIN 2% OINTMENT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1456 per GM |
|---|---|
| All-time high | $0.3471 (Feb 11, 2015) |
| All-time low | $0.1322 (Mar 18, 2026) |
| 52-week high | $0.1468 |
| 52-week low | $0.1322 |
| Median price | $0.1940 |
| Average price | $0.2136 |
| Largest weekly change | -21.0% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mupirocin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
RNA Synthetase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUPIROCIN 2% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for MUPIROCIN 2% OINTMENT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1456 per GM (NDC 68462018022), effective Sep 30, 2026.
How has the price of MUPIROCIN 2% OINTMENT changed over time?
Over the history we have for it, the NADAC for MUPIROCIN 2% OINTMENT has declined 53.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MUPIROCIN 2% OINTMENT?
Since Nov 28, 2013, the NADAC for MUPIROCIN 2% OINTMENT has ranged from a low of $0.1322 (Mar 18, 2026) to a high of $0.3471 (Feb 11, 2015), with a median of $0.1940 per GM.
Are there cheaper alternatives to MUPIROCIN 2% OINTMENT?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MUPIROCIN 2% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures MUPIROCIN 2% OINTMENT?
MUPIROCIN 2% OINTMENT (NDC 68462018022) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.